摘要
目的探讨中国6个碘适宜地区不同吸烟状态与甲状腺功能减退症(甲减)的关系。方法在6个城市中采取整群抽样的方法调查了常住居民8 187人,最终纳入7 448人,详细填写流行病学调查问卷,测量身高、体重、腰围及血压,采集血样检测促甲状腺激素(TSH)、甲状腺过氧化物酶抗体(TPOAb)和甲状腺球蛋白抗体(TgAb)。结果被动吸烟和主动吸烟组TSH均值、TPOAb阳性率、TgAb阳性率均低于从不吸烟组(均P<0.01)。主动吸烟组人群中,吸烟指数每增加1个单位,TSH值下降0.023个单位。被动吸烟和主动吸烟组对比不吸烟组,TgAb和TPOAb阳性率均降低(均P<0.01)。主动吸烟和被动吸烟者甲减的患病率降低(均P<0.01)。在女性人群中,主动吸烟组和被动吸烟组临床甲减和亚临床甲减患病的风险降低。在吸烟指数大于70的情况下,亚临床甲减患病的风险明显下降。在男性人群中,主动吸烟组和被动吸烟组亚临床甲减患病的风险降低,且在吸烟指数大于70的情况下,临床甲减、亚临床甲减的患病风险明显下降。结论碘适宜地区吸烟可能降低TSH水平及TPOAb、TgAb阳性率。
Objective To explore the relationship between different smoking status and hypothyroidism in six iodine-suitable areas of China. Methods A total of 8 187 residents were investigated by cluster sampling in six cities, and 7 448 residents were included in the survey. The height, weight, waist circumference, and blood pressure were measured by filling out epidemiological questionnaire. Blood samples were collected to detect thyroid stimulating hormone (TSH), thyroid peroxidase antibody (TPOAb), and thyroglobulin antibody (TgAb). Results The mean TSH, TPOAb, and TgAb positive rates in passive smoking and active smoking groups were all lower than those in non-smoking group (all P<0.01). In the active smoking group, the TSH value decreased by 0.023 units for every unit increase in smoking index. The positive rates of TgAb and TPOAb in both passive smoking and active smoking groups were lower than those in non-smoking group (all P<0.01). Active and passive smoking reduced the prevalence of hypothyroidism (both P<0.01). Among women, the risks of clinical hypothyroidism and subclinical hypothyroidism were reduced in both active and passive smoking groups. Besides, the risk of subclinical hypothyroidism decreased significantly when the smoking index was more than 70. In male population, the risk of subclinical hypothyroidism in active and passive smoking group decreased. Besides, the risk of clinical hypothyroidism and subclinical hypothyroidism decreased significantly when the smoking index was more than 70. Conclusion Smoking in iodine-suitable areas may reduce TSH level and the positive rates of TPOAb and TgAb.
作者
戴雨桑
时立新
张巧
彭年春
陈璐璐
连小兰
刘超
单忠艳
施秉银
童南伟
王曙
翁建平
赵家军
滕卫平
Dai Yusang;Shi Lixing;Zhang Qiao;Peng Nianchun;Chen Lulu;Lian Xiaolan;Liu Chao;Shan Zhongyan;Shi Bingyin;Tong Nanwei;Wang Shu;Weng Jianping;Zhao Jiajun;Teng Weiping(Department of Endocrinology and Metabolism, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China;Department of Endocrinology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China;Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China;Department of Endocrinology, Jiangsu Integrated Traditional Chinese and Western Medicine Hospital, Nanjing 210028, China;Institute of Endocrinology, Department of Endocrinology, First Affiliated Hospital of China Medical University, Shenyang 110001, China;Department of Endocrinology, First Affiliated Hospital of Xi′an Jiaotong University, Xi′an 710061, China;Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China;Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai 200025, China;Department of Endocrinology and Metabolism, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China)
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2019年第6期475-479,共5页
Chinese Journal of Endocrinology and Metabolism